| Year |
Citation |
Score |
| 2010 |
Seo JH, Wood LJ, Agarwal A, O'Hare T, Elsea CR, Griswold IJ, Deininger MW, Imamoto A, Druker BJ. A specific need for CRKL in p210BCR-ABL-induced transformation of mouse hematopoietic progenitors. Cancer Research. 70: 7325-35. PMID 20807813 DOI: 10.1158/0008-5472.Can-10-0607 |
0.364 |
|
| 2009 |
Johnson KJ, Griswold IJ, O'Hare T, Corbin AS, Loriaux M, Deininger MW, Druker BJ. A BCR-ABL mutant lacking direct binding sites for the GRB2, CBL and CRKL adapter proteins fails to induce leukemia in mice. Plos One. 4: e7439. PMID 19823681 DOI: 10.1182/Blood.V104.11.718.718 |
0.458 |
|
| 2006 |
Griswold IJ, MacPartlin M, Bumm T, Goss VL, O'Hare T, Lee KA, Corbin AS, Stoffregen EP, Smith C, Johnson K, Moseson EM, Wood LJ, Polakiewicz RD, Druker BJ, Deininger MW. Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib Molecular and Cellular Biology. 26: 6082-6093. PMID 16880519 DOI: 10.1182/Blood.V108.11.4796.4796 |
0.413 |
|
| 2005 |
Corbin AS, Demehri S, Griswold IJ, Wang Y, Metcalf CA, Sundaramoorthi R, Shakespeare WC, Snodgrass J, Wardwell S, Dalgarno D, Iuliucci J, Sawyer TK, Heinrich MC, Druker BJ, Deininger MW. In vitro and in vivo activity of ATP-based kinase inhibitors AP23464 and AP23848 against activation-loop mutants of Kit. Blood. 106: 227-34. PMID 15746079 DOI: 10.1182/Blood-2004-12-4771 |
0.381 |
|
| 2004 |
Corbin AS, Griswold IJ, La Rosée P, Yee KW, Heinrich MC, Reimer CL, Druker BJ, Deininger MW. Sensitivity of oncogenic KIT mutants to the kinase inhibitors MLN518 and PD180970. Blood. 104: 3754-7. PMID 15304388 DOI: 10.1182/Blood-2004-06-2189 |
0.362 |
|
| 2004 |
Griswold IJ, Shen LJ, La Rosée P, Demehri S, Heinrich MC, Braziel RM, McGreevey L, Haley AD, Giese N, Druker BJ, Deininger MW. Effects of MLN518, a dual FLT3 and KIT inhibitor, on normal and malignant hematopoiesis. Blood. 104: 2912-8. PMID 15242881 DOI: 10.1182/Blood-2003-05-1669 |
0.334 |
|
| 2004 |
Corbin AS, Demehri S, Griswold IJ, Metcalf CA, Shakespeare WC, Snodgrass J, Wardwell S, Dalgarno DC, Iuliucci J, Sawyer TK, Druker BJ, Deininger MW. In Vitro and In Vivo Activity of the Src/Abl Kinase Inhibitor AP23464 and Analogs Against Activation Loop Mutants of KIT. Blood. 104: 793-793. DOI: 10.1182/Blood.V104.11.793.793 |
0.388 |
|
| 2004 |
Griswold IJ, Bumm T, O’Hare T, Moseson EM, Druker BJ, Deininger MW. Investigation of the Biological Differences between Bcr-Abl Kinase Mutations Resistant to Imatinib. Blood. 104: 555-555. DOI: 10.1182/Blood.V104.11.555.555 |
0.366 |
|
| 2002 |
Griswold IJ, Dahlquist FW. The dynamic behavior of CheW from Thermotoga maritima in solution, as determined by nuclear magnetic resonance: implications for potential protein-protein interaction sites. Biophysical Chemistry. 101: 359-73. PMID 12488014 DOI: 10.1016/S0301-4622(02)00157-6 |
0.513 |
|
| 2002 |
Griswold IJ, Dahlquist FW. Bigger is better: megadalton protein NMR in solution. Nature Structural Biology. 9: 567-8. PMID 12145644 DOI: 10.1038/Nsb0802-567 |
0.467 |
|
| 2002 |
Griswold IJ, Zhou H, Matison M, Swanson RV, McIntosh LP, Simon MI, Dahlquist FW. The solution structure and interactions of CheW from Thermotoga maritima. Nature Structural Biology. 9: 121-5. PMID 11799399 DOI: 10.1038/Nsb753 |
0.533 |
|
| 2000 |
Quillin ML, Breyer WA, Griswold IJ, Matthews BW. Size versus polarizability in protein-ligand interactions: binding of noble gases within engineered cavities in phage T4 lysozyme. Journal of Molecular Biology. 302: 955-77. PMID 10993735 DOI: 10.1006/Jmbi.2000.4063 |
0.352 |
|
| Show low-probability matches. |